Interleukin-10 as a marker of disease progression in dengue hemorrhagic fever

Journal of the College of Physicians and Surgeons Pakistan

Volumn 26, Issue 3, 2016, Pages 187-190

  Tauseef, Ambreen ^a   Umar, Naima ^b   Sabir, Sana ^c   Akmal, Ayesha ^a   Sajjad, Saadia ^d   Zulfiqar, Sibgha ^e  

^a National University of Medical Sciences   (Pakistan)

^b Fatima Memorial College of Medicine and Dentistry   (Pakistan)

^c KHAWAJA MUHAMMAD SAFDAR MEDICAL COLLEGE   (Pakistan)

^d SUPERIOR UNIVERSITY   (Pakistan)

^e Shaikh Zayed PGMI ^*  (Pakistan)

Author keywords

Cytokines; Dengue hemorrhagic fever; Immunopathogenesis; Interleukin 10; Outcome

Indexed keywords

INTERLEUKIN 10; AUTACOID; BIOLOGICAL MARKER; IL10 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DENGUE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ELISA KIT; FATALITY; FEMALE; HEMORRHAGIC SHOCK; HOSPITAL ADMISSION; HUMAN; MALE; PLASMA; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TIME TO TREATMENT; BLOOD; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PAKISTAN; SEVERE DENGUE; SEVERITY OF ILLNESS INDEX; THROMBOCYTE COUNT; TIME FACTOR;

ADOLESCENT; ADULT; BIOMARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; MALE; MIDDLE AGED; PAKISTAN; PLATELET COUNT; SEVERE DENGUE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84977587606     PISSN: 1022386X     EISSN: 16817168     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10:100-3.
2. Dengue and severe dengue. Available from http://www.who.int/mediacentre/factsheets/fs117/en. Accessed on 8/10/15
3. Halstead SB. Dengue. Lancet 2007; 370:1644-52.
4. Riaz MM, Mumtaz K, Khan MS, Patel J, Tariq M, Hilal H, et al. Outbreak of dengue fever in Karachi 2006: a clinical perspective. J Pak Med Assoc 2009; 59:339-44.
5. Chaturvedi UC, Nagar R. Nitric oxide in dengue and dengue hemorrhagic fever: necessity or nuisance? FEMS Immunol Med Microbiol 2009; 56:9-24.
6. Srikiatkhachorn A, Green S. Markers of dengue disease severity. Curr Top Microbiol Immunol 2010; 338:67-82.
7. Mangada MM, Rothman AL. Altered cytokine responses of dengue-specific CD4+ T-cells to heterologous serotypes. J immunol 2005; 175:2676-83.
8. Tang Y, Kou Z, Zhang F, Yao X, Liu S, Ma J. Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue1 infection among adult Chinese patients. PLoS one 2010; 5:1-8.
9. Tsai TT, Chuang YJ, Lin YS, Wan SW, Chen CL, Lin CF. An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. J Biomed Sci 2013; 20:40.
10. Malavige GN, Fernando N, Ogg G. Pathogenesis of dengue viral infections. Sri Lankan J Infect Dis 2011; 1:2-8.
11. Bozza FA, Cruz OG, Zagne S, Azeredo EL, Nogueira R, Assis EF. Multiple cytokine profile from dengue patients: MIP-l beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 2008; 8:86.
12. Fang X, Hu Z, Shang W, Zhu J, Xu C, Rao X. Genetic polymorphisms of molecules involved in host immune response to dengue virus infection. FEMS Immunol Med Microbiol 2012; 66:134-46.
13. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach. Pharm Rev 2003; 55:2241-69.
14. Green S, Rothman A. Immunopathological mechanism in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 2006; 19: 429-36.
15. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL. Dengue viral infections. Postgrad Med J 2004; 80:588-601.
16. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, Le BL. Dengue hemorrhagic fever in infants: A study of clinical and cytokine profiles. J Infect Dis 2004; 189:221-32.
17. Gurugama P, Garg P, Perera J, Wijewickrama A, Seneviratne SL. Dengue viral infections. Indian J Dermatol 2010; 55:68-78.
18. Ubol S, Phuklia W, Kalayanarooj S, Modhiran N, Mechanism of immune evasion induced by a complex of dengue virus and pre-existing enhancing antibodies. J Infect Dis 2010; 201: 923-35.
19. Brasier AR, Ju H, Garcia J, Spratt HM, Victor SS, Forshey BM, et al. A three-component biomarker panel for prediction of dengue hemorrhagic fever. Am J Med Hyg 2012; 86: 341-8.
20. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006; 12:1301-9.
21. Sierra B, Perez AB, Vogt K, Garcia G, Schmolke K, Aguirre E, et al. Secondary heterologous dengue infection risk: disequilibrium between immune regulation and inflammation? Cell Immunol 2010; 262:134-40.
22. Perez AB, Sierra B, Garcia G, Aguirre E, Babel N, Alvarez M, et al. Tumor necrosis factor-alpha, transforming growth factor-β, 1 and interleukin-10 gene polymorphism: implication in protection or susceptibility to dengue. Hum Immunol 2010; 71:1135-40.